Skip to content

TransMind

Transforming body and emotional awareness in transgender individuals through Mindfulness-based intervention - TransMind

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57529
Enrollment
12
Registered
2025-02-05
Start date
2025-05-07
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gender dysphoria, psychological distress

Interventions

We will offer an 8-week mindfulness program (MBCT-L) that was developed by the University of Oxford Mindfulness Centre. It will be adapted in language for use in a gender-diverse population (18 - 50 y

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Trans and gender-diverse individuals who have received or are currently receiving medical transgender care. Age between 18 and 50 years.Provide written informed consent. Adequate mastery of English or Dutch language.Sufficient proficiency in English to complete questionnaires.

Exclusion criteria

Exclusion criteria: Moderate to severe mental health problems, based on questionnaire DSM-XC scores above 2 [Mild symptoms] on a 5 point (0-4) Likert scale. Recent (less than 5 years ago) participation in an 8-week mindfulness program

Design outcomes

Primary

MeasureTime frame
Primary outcomes include self-ratings of body awareness on the Multidimensional Assessment of Interoceptive Awareness (MAIA) and emotion regulation on the Difficulties Emotion Regulation Scale (DERS).

Secondary

MeasureTime frame
Secondary outcomes include self-report measures of perceived stress,rumination, alexithymia, experiential avoidance, positive and negative affect, emotional well-being, mindfulness skills, self-compassion, and decentering.

Countries

Netherlands

Contacts

Public ContactG. Collin

Radboud Universitair Medisch Centrum

Guusje.collin@radboudumc.nl(024) 30 98 988

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 7, 2026